These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 16406798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N.
    Clin Infect Dis; 2001 Mar 01; 32(5):742-51. PubMed ID: 11229841
    [Abstract] [Full Text] [Related]

  • 5. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP.
    Semin Respir Infect; 2002 Dec 01; 17(4):265-73. PubMed ID: 12497543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF, Hodson EM, Jones C, Craig JC.
    Transplantation; 2006 Jan 27; 81(2):139-45. PubMed ID: 16436954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Late-onset cytomegalovirus disease in patients with solid organ transplant.
    Meylan PR, Manuel O.
    Curr Opin Infect Dis; 2007 Aug 27; 20(4):412-8. PubMed ID: 17609602
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
    Steininger C.
    Clin Microbiol Infect; 2007 Oct 27; 13(10):953-63. PubMed ID: 17803749
    [Abstract] [Full Text] [Related]

  • 15. [Cytomegalovirus infection in transplant recipients].
    Gondo H.
    Nihon Rinsho; 1998 Jan 27; 56(1):173-8. PubMed ID: 9465685
    [Abstract] [Full Text] [Related]

  • 16. Strategies for managing cytomegalovirus in transplant recipients.
    Razonable RR.
    Expert Opin Pharmacother; 2010 Aug 27; 11(12):1983-97. PubMed ID: 20642369
    [Abstract] [Full Text] [Related]

  • 17. Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy.
    Singh N.
    Rev Med Virol; 2006 Aug 27; 16(5):281-7. PubMed ID: 16878336
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
    Singh N.
    Clin Infect Dis; 2005 Mar 01; 40(5):704-8. PubMed ID: 15714416
    [No Abstract] [Full Text] [Related]

  • 20. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA, Snydman DR.
    Curr Opin Infect Dis; 2007 Aug 01; 20(4):419-24. PubMed ID: 17609603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.